DiaMedica Therapeutics, Inc. (DMAC)
8.04
-0.43
(-5.08%)
USD |
NASDAQ |
Jan 30, 16:00
8.045
0.00 (0.00%)
After-Hours: 19:51
DiaMedica Therapeutics Market Cap : 418.70M for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 317.87M |
| Avantor, Inc. | 7.449B |
| NovaBay Pharmaceuticals, Inc. | 234.68M |
| Palatin Technologies, Inc. | 13.76M |
| Theriva Biologics, Inc. | 6.022M |
Market Cap Related Metrics
| PEG Ratio | -0.3769 |
| Price to Book Value | 8.111 |
| Price | 8.04 |
| Earnings Yield | -8.92% |
| PEGY Ratio | -0.3769 |